Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Healthstream (HSTM) Enterprise Value (2016 - 2026)

Healthstream has reported Enterprise Value over the past 16 years, most recently at -$57.0 million for Q4 2025.

  • Quarterly Enterprise Value rose 41.36% to -$57.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$57.0 million through Dec 2025, up 41.36% year-over-year, with the annual reading at -$57.0 million for FY2025, 41.36% up from the prior year.
  • Enterprise Value was -$57.0 million for Q4 2025 at Healthstream, up from -$92.6 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$39.2 million in Q2 2022 and troughed at -$113.3 million in Q1 2025.
  • The 5-year median for Enterprise Value is -$59.6 million (2021), against an average of -$69.2 million.
  • Year-over-year, Enterprise Value surged 60.59% in 2021 and then crashed 48.31% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$51.9 million in 2021, then decreased by 3.78% to -$53.9 million in 2022, then plummeted by 31.95% to -$71.1 million in 2023, then crashed by 36.67% to -$97.2 million in 2024, then skyrocketed by 41.36% to -$57.0 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Enterprise Value are -$57.0 million (Q4 2025), -$92.6 million (Q3 2025), and -$90.6 million (Q2 2025).